Point72 Middle East FZE »

Travere Therapeutics shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $326k 36k 8.99
2023-09-30 $224k 25k 8.94
2023-06-30 $206k 13k 15.36

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Travere Therapeutics

Vanguard Group
Deutsche Bank Aktiengesellschaft
Kynam Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of America Corporation
Goldman Sachs Group
Millennium Management
Emerald Advisers
Avidity Partners Management
Emerald Mutual Fund Advisers, Trust
Schonfeld Strategic Advisors
Barclays
Healthcare Of Ontario Pension Plan Trust Fund
Two Sigma Advisers

View all funds holding Travere Therapeutics